Why the study?
What are the clinical differences and general conclusions drawn from the development of nitrosoureas (BCNU, CCNU, MeCCNU)?
What are the clinical differences and general conclusions drawn from the development of nitrosoureas (BCNU, CCNU, MeCCNU)?
This review summarizes the preclinical development and clinical data of three nitrosourea antitumor agents.
No takes yet. Share an insight, caveat, or question.
Provides comparative overview of nitrosourea agents; leaves open their role in contemporary regimens pending updated trials.
Wasserman et al. (1975) studied this question.